ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 129 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $237 | +5.8% | 106,722 | +28.0% | 0.00% | 0.0% |
| Q1 2024 | $224 | -45.4% | 83,400 | -67.6% | 0.00% | -33.3% |
| Q1 2023 | $410 | -94.4% | 257,584 | -78.0% | 0.00% | -97.2% |
| Q4 2022 | $7,300 | -99.7% | 1,171,799 | +221.1% | 0.11% | +231.2% |
| Q3 2022 | $2,445,000 | +1498.0% | 364,951 | +1420.2% | 0.03% | +1500.0% |
| Q2 2022 | $153,000 | -22.3% | 24,007 | -43.5% | 0.00% | 0.0% |
| Q1 2022 | $197,000 | +181.4% | 42,506 | +201.9% | 0.00% | +100.0% |
| Q4 2021 | $70,000 | -90.8% | 14,079 | -77.8% | 0.00% | -90.0% |
| Q3 2021 | $765,000 | – | 63,460 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 1,275,000 | $45,020,000 | 9.84% |
| Aviva Holdings Ltd. | 340,100 | $12,009,000 | 5.60% |
| Aisling Capital LLC | 837,125 | $29,559,000 | 5.38% |
| RA Capital Management | 704,701 | $24,883,000 | 3.05% |
| Rhenman & Partners Asset Management AB | 543,347 | $19,186,000 | 3.04% |
| BB BIOTECH AG | 1,408,542 | $49,736,000 | 1.63% |
| Antipodean Advisors LLC | 91,000 | $3,213,000 | 1.57% |
| Iguana Healthcare Management, LLC | 75,000 | $2,648,000 | 1.31% |
| Crawford Lake Capital Management, LLC | 93,551 | $3,303,000 | 1.31% |
| FT Options LLC | 22,834 | $806,000 | 1.06% |